UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001413
Receipt number R000001716
Scientific Title Phase 2 study of induction and early consolidation therapy for acute lymphoblastic leukemia in children (TCCSG ALL L04-16).
Date of disclosure of the study information 2008/10/05
Last modified on 2010/10/30 14:29:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Phase 2 study of induction and early consolidation therapy for acute lymphoblastic leukemia in children (TCCSG ALL L04-16).

Acronym

Phase 2 study of induction and early consolidation therapy for ALL in children (TCCSG ALL L04-16).

Scientific Title

Phase 2 study of induction and early consolidation therapy for acute lymphoblastic leukemia in children (TCCSG ALL L04-16).

Scientific Title:Acronym

Phase 2 study of induction and early consolidation therapy for ALL in children (TCCSG ALL L04-16).

Region

Japan


Condition

Condition

Acute Lymphoblastic Leukemia

Classification by specialty

Hematology and clinical oncology Pediatrics

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to investigate efficacy and safety for treating pediatric ALL with conventional induction and early consolidation therapy.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2

Pragmatic

Developmental phase

Phase II


Assessment

Primary outcomes

The rate of complete remission at the completion of early consolidation.

Key secondary outcomes

1.The complete remission induction rate
2.The frequency of therapy toxicity


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

For standard and intermediate risk patients;
Induction therapy-A (Week 1-6): PSL, VCR, THP-ADR, L-ASP, MTX, Ara-C, HDC.
Consolidation therapy-A for standard and intermediate risk patients (Week 8-10): 6MP, Ara-C, CPM, MTX, HDC.
For high risk patients;
Induction therapy-B (Week 1-6): PSL, VCR, THP-ADR,DNR, CPA, L-ASP, MTX, Ara-C, HDC.
Early Consolidation therapy-B (Week 8): DEX, MTX, CPA, Ara-C, L-ASP, HDC.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

1 years-old <=

Age-upper limit

18 years-old >

Gender

Male and Female

Key inclusion criteria

(1) Previously untreated ALL,
(2) Age between 1 and 18 years,
(3) Karnofsky Performance status score >50,
(5) Written informed consent to participate the trial.

Key exclusion criteria

(1)Symptomatic intracranial hemorrhage
(2) Uncontroled infection,
(3) Double cancer, Secondary leukemia,
(4) Down syndrome,
(5) Pregnant, lactating woman,
(6) Inadequate functioning of the liver (ALT>200 and serum total bilirubin level > 1.5 mg/dL), kidneys (serum creatinine level >= 1.5 mg/dL),
(7) cardiac dysfunction, pulmonary dysfunction

Target sample size

300


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Akira Ohara

Organization

Toho University

Division name

Omori Hospital, Dep.of Transfusion

Zip code


Address

6-11-1, Omori-Nishi, Ota-ku, Tokyo

TEL

03-3762-4151

Email



Public contact

Name of contact person

1st name
Middle name
Last name Akira Ohara

Organization

Toho University

Division name

Omori Hospital, Dep.of Transfusion

Zip code


Address

6-11-1, Omori-Nishi, Ota-ku, Tokyo

TEL

03-3762-4151

Homepage URL


Email

aohara@med.toho-u.ac.jp


Sponsor or person

Institute

Tokyo Children's Cancer Study Group

Institute

Department

Personal name



Funding Source

Organization

1.Ministry of Health, Labor and Welfare, "Study on establishment of the multicenter clinical study for standard therapy to pediatric sarcoma"
2.Children's Cancer Association of Japan

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2008 Year 10 Month 05 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

Interim analysis of the 150 patients. Complete remission rate at completion of early consolidation is estimated as 97%. No unexpected treatment toxicity was reported.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2004 Year 11 Month 25 Day

Date of IRB


Anticipated trial start date

2004 Year 12 Month 01 Day

Last follow-up date

2010 Year 07 Month 01 Day

Date of closure to data entry

2010 Year 08 Month 01 Day

Date trial data considered complete

2010 Year 10 Month 01 Day

Date analysis concluded

2010 Year 12 Month 01 Day


Other

Other related information



Management information

Registered date

2008 Year 10 Month 02 Day

Last modified on

2010 Year 10 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001716


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name